Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study

INTRODUCTION: Pranlukast is a leukotriene receptor antagonist (LTRA) that is used as an additional controller of mild to moderate asthma. This study compared the efficacy and side effects of two bioequivalent preparations of pranlukast: original pranlukast (Onon(®); Ono Pharmaceutical, Japan) and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo W., Kim, Hunam, Ryu, Yon J., Lee, Jin H., Shim, Sung S., Kim, Yoo K., Chang, Jung H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951783/
https://www.ncbi.nlm.nih.gov/pubmed/27499820
http://dx.doi.org/10.2174/1874306401610010036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951783/
https://www.ncbi.nlm.nih.gov/pubmed/27499820
http://dx.doi.org/10.2174/1874306401610010036

Ejemplares similares